Wealth Enhancement Trust Services
MLAB icon

Wealth Enhancement Trust Services’s Mesa Laboratories MLAB Stock Holding History

Wealth Enhancement Trust Services’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-20
Closed -$1.99K – 1210
2026
Q2 		$1.99K Buy
+20
New +$2.01K ﹤0.01% 1004

Other funds holding MLAB

Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.31B AUM 40.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Wealth Enhancement Trust Services's MLAB Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of Mesa Laboratories (MLAB) in Q3 2026, closing a stake of 20 shares — an estimated $1.99K sold.

Wealth Enhancement Trust Services first reported a position in MLAB in Q2 2026 and held it in 1 quarter. The position peaked at $1.99K in Q2 2026. 128 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining Mesa Laboratories position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 20 Mesa Laboratories shares in Q3 2026, an estimated $1.99K.
  • Wealth Enhancement Trust Services first reported a position in Mesa Laboratories in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's Mesa Laboratories position peaked at $1.99K in Q2 2026.
  • 128 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.